Amol Deshmukh’s Post

The World Cancer Day is observed globally to aware common public about the preventive measures of this harmful disease that is the second-leading cause of death worldwide. prevention is better than cure means it's easier to stop something happening in the first place than to repair the damage after it has happened. so every Pharmacist / Scientists/ Chemist/Related Pharma MFG also aware about the ICH M7 guidelines, Q3D ( R1) , NItrosamine impurity assessment, Genotoxic impurity assessment, Elemental impurity assessment and in fact aware about ICH guidelines to prevent Cancer some extent From : AVD Pharmaceuticals Pvt Ltd #worldcancarday #Ichguidelines #ichm7 #ichq3d #NItrosamineimpurityassessment #genotoxicimpuritieassesment #elementalimpuritiesassesment #cancer #cacerawareness #pharmaindustry #foodindustry #cosmaticindustry #agrochem #specilitychemicals #drugsubstance #drugproducts #who #standtogetheragainestcancer https://lnkd.in/dwPW7Jsm

#Didyouknow Bone cancer can start in any bone, but it most often affects the thigh bone. Despite its seriousness, only 1% of all cancers are bone cancers. This rare disease primarily affects children, teenagers, and young adults, with osteosarcoma being the most common type. Raising awareness about these facts is crucial for early detection and treatment. #BoneCancerAwareness #HealthMatters For More Information +91 78618 51969 globelapharma.com #Globelapharma #Indianpharma #pharmacy #pharmaproducts #healthcareheroes #servinglife #affordability #innovation #APImedicine #pharma #worldwidepharma #Generics #TrustAndExcellence

Cancer includes a complex group of diseases that is characterized by uncontrolled growth and spread of abnormal cells in the body. Read more: https://lnkd.in/gJSscKtt #worldcancerday2024 #cancerday #cancerawareness #mrmed #superspecialitymedicine #pharmacy

Just watched an interesting video on using circulating tumor DNA (ctDNA) to help patients with low-risk colorectal cancer. The video does a great job explaining how ctDNA testing could help inform treatment decisions and follow-up care for people with early-stage CRC. It's interesting to see how advances in molecular diagnostics are empowering more personalized cancer management. If you or a loved one has been touched by colorectal cancer, I'd recommend checking out this video. It's a quick watch but covers an important topic. Definitely worth a look if you want to learn more about how cutting-edge science is improving CRC care. Let me know what you think if you have a chance to view it! 🧬#Natera Watch here: https://ow.ly/9qW850SY5Ka

Just watched an interesting video on using circulating tumor DNA (ctDNA) to help patients with low-risk colorectal cancer. The video does a great job explaining how ctDNA testing could help inform treatment decisions and follow-up care for people with early-stage CRC. It's interesting to see how advances in molecular diagnostics are empowering more personalized cancer management. If you or a loved one has been touched by colorectal cancer, I'd recommend checking out this video. It's a quick watch but covers an important topic. Definitely worth a look if you want to learn more about how cutting-edge science is improving CRC care. Let me know what you think if you have a chance to view it! 🧬#Natera Watch here: https://ow.ly/rlEY50SXkRN

Just watched an interesting video on using circulating tumor DNA (ctDNA) to help patients with low-risk colorectal cancer. The video does a great job explaining how ctDNA testing could help inform treatment decisions and follow-up care for people with early-stage CRC. It's interesting to see how advances in molecular diagnostics are empowering more personalized cancer management. If you or a loved one has been touched by colorectal cancer, I'd recommend checking out this video. It's a quick watch but covers an important topic. Definitely worth a look if you want to learn more about how cutting-edge science is improving CRC care. Let me know what you think if you have a chance to view it! 🧬#Natera Watch here: https://ow.ly/I54B50SVwt9

🩺Using #ctDNA to help inform the management of patients with low-risk colorectal cancer. #CRC #CRCManagement #Oncology #Natera Watch the full video here: https://ow.ly/8lBC50SLb2v

In case you missed it, Pfizer has agreed to settle more than 10,000 cases that accused it of hiding the cancer risks of Zantac (ranitidine). https://buff.ly/3yeQsLn Zantac was available as an over-the-counter antacid in the US until April 2020 when it was recalled. The concern was that NDMA, a potential carcinogen was found in some ranitidine. But before you get too worried, a large-scale study https://buff.ly/4dxxzDL of nearly 1.2 million people in 2023 found that people who took Zantac for at least a month were no more likely to develop cancer than people who took similar drugs such as Pepcid (famotidine). #patientadvocate #mymdadvisor #medicalguide #medicalnavigator #medicaladvocate #zantac #cancerrisk #zantacrecall #zantacsettlement

A significant development for Johnson & Johnson! Expanding their production capabilities for biologic medicines could have a substantial impact on the treatment of cancer, immunity-related, and neurological diseases. Biologics are often at the forefront of innovative treatments, offering new hope for patients with complex conditions. This expansion could also mean more job opportunities in the biotech sector and potentially faster delivery of these critical medicines to patients in need. How do you think this might influence the broader healthcare landscape and the availability of advanced treatments?